Suppression of PAI-I mRNAs in experimental animals after administration of PAI-1 inhibitors have been also demonstrated previously in other kidney disease models, such as the anti-Thy-1 rat glomerulonephritis model [33] as well as in the rodent multiple sclerosis model [34]. The gene discussed is THY1; the disease is kidney disorder.